The South Korean government announced this month plans for four ministries to contribute $301 million to stimulate the development and production of stem cell and genetic drugs for export. According to the Ministry of Food and Drug Safety, in 2014, South Korea had the second-highest number of projects in stem cell–drug development globally, at 40. […]
The conclusions of a January meeting of stakeholders in genome engineering were published this month in Science. The group called for research on the safety of using CRISPR-Cas9 technology. According to the stakeholders, understanding the technology’s risks is necessary before endorsing its use in clinical testing, and they recommend several actions in the meantime. The […]
Since October 2014, plummeting crude oil prices have resulted in a 46% drop in the number of US rigs drilling for oil, job cuts, and drops in profits and investment in the US shale industry. Nonetheless, output of shale oil remains steady, with potential for growth over the next two years. Although a decline in […]
In March, the US Office of Science and Technology Policy (OSTP) issued a report on the budget authority for federal R&D-facilities construction and major capital equipment (R&D infrastructure) in President Obama’s fiscal year 2016 (FY16) budget. The report included actual FY14 and estimated FY15 budget authorities for R&D infrastructure, which is defined as support for […]
US equity markets wavered in March due to the Federal Reserve’s ambiguous wordplay on raising interest rates and concerns over corporate profits due to the strengthening US dollar. The Fed continues to be unnerved by the fragility of the economy and growing market risks associated with loose monetary policies. The latest US GDP estimate for […]
Jena, Germany 3/26/15—Germany’s Analytik Jena delisted its shares from the Frankfurt Stock Exchange effective March 26 (see IBO 9/30/14). “The shareholder structure means that Analytik Jena AG does not have to be listed on the stock exchange anymore,” stated Analytik CEO Klaus Berka. “In particular, we no longer rely on the possibility of raising capital […]
Andover, MA 3/18/15—MKS Instruments, a provider of instruments, subsystems and process-control solutions, has acquired Precisive for $13 million in cash. Precisive develops optical analyzers based on Tunable Filter Spectroscopy (TFS) for real-time gas analysis in the natural gas and hydrocarbon-processing industries. Precisive has over 2,500 systems deployed. “We have previously said we are looking for […]
Santa Clara, CA 3/18/15–Agilent Technologies has elected president and COO Mike McMullen as CEO, effective March 18, as part of a previously announced transition (see IBO 9/30/14). Former CEO William (Bill) Sullivan will serve as an advisor until October 31. “We are well positioned to capture new opportunities in our life sciences and diagnostics markets, […]
St. Louis, MO 3/19/15; Pleasanton, CA 3/19/15—Sigma-Aldrich and Roche have signed an exclusive global distribution agreement under which Sigma-Aldrich will distribute Roche’s Biochemical Reagents product portfolio. Roche’s Biochemical Reagents products include kits and enzymes for cellular analysis, proteomics and conventional PCR applications. The transition will take place this year. “This agreement allows us to provide […]
Tokyo, Japan and Santa Clara, CA 3/30/15—Japan-based scientific-instrument firm Rigaku has agreed to acquire Agilent Technologies’ XRD business for an undisclosed amount. The XRD business provides single-crystal x-ray instruments for chemical crystallography. “The acquisition of Agilent’s x-ray crystallography business represents a significant step in the expansion of our single-crystal x-ray business,” said Rigaku President and […]
Pay Invoice
Latest Blogs
-
Lab Instrument Sales in China Collapse
March 29, 2024 1:15 pm
-
Pittcon 2024 Comes to San Diego
February 14, 2024 1:10 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
